08:00 , Jan 4, 2016 |  BC Week In Review  |  Company News

Microlin Bio, American Boarding deal

Microlin Bio reverse-merged with American Boarding. Microlin Bio is developing microRNA-based therapies for cancer. Its lead candidate, lumiralin ( AM-21 ), an anti- microRNA-21 (miR-21) , is in preclinical testing to treat lung cancer. Microlin...